Probiodrug AG

(PRBGF)

By |

Profile

Probiodrug AG is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease. The company's development pipeline consists of the product candidates; PQ912 which is a specific and potent inhibitor of Glutaminyl Cyclase; PBD-C06 which is a monoclonal antibody that targets pGlu-Abeta, aiming to selectively clear the brain of pGlu-Abeta while leaving non-toxic forms of Abeta untouched; and PQ1565 which is a second QC-inhibitor that has shown drug-like properties in preclinical studies.

Contact Information

Website: www.probiodrug.de
Main Phone: +49 3455559900
Address: Weinbergweg 22
City / Town: Halle
Country: DEU
Postal Code: 06120

Issuer Information

Exchange: GREY
Employees: 13
$ 17.25 $ 0. (0.00%)
Last Price 17.25 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 17.25
Last Trade Volume 0 52 Wk Hi 17.35 52 Wk Low 17.25
Market Cap 141.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,186,735.00 EPS (TTM) -1.62 PE Ratio N/A Exchange Greys